On Friday, Shares of Sabre Corp (NASDAQ:SABR), lost -0.18% to $28.48.
Sabre Corporation (SABR), has named Dana Jones senior vice president, new market development. This role, reporting to Sabre President and CEO Tom Klein, reinforces Sabre’s commitment to better support travel businesses in China in addition to to expand Sabre’s technology solutions to travel buyers and sellers on the African continent.
“China and Africa are two of the world’s fastest growing geographies for travel. Dana’s leadership role will assist best position Sabre for growth in these regions with our current technology offerings in addition to through the development of new business opportunities,” said Tom Klein.
In this new role, Jones will be responsible for leading an enterprise strategy aimed at accelerating investment and the development and delivery of software solutions in China and Africa.
Sabre Corporation provides technology solutions to the travel and tourism industry worldwide. It operates in two segments: Travel Network, and Airline and Hospitality Solutions.
Shares of Oneok Partners LP (NYSE:OKS), declined -2.69% to $32.17, during its last trading session.
ONEOK, and ONEOK Partners, L.P. (OKS), took part at the Barclays CEO Energy Conference Sept. 8-9, 2015 in New York City.
Terry K. Spencer, ONEOK and ONEOK Partners president and chief executive officer, presented at the conference at 1:45 p.m. Eastern Daylight Time (12:45 p.m. Central Daylight Time) on Tuesday, Sept. 8.
Spencer and Walter S. Hulse III, ONEOK and ONEOK Partners executive vice president of planned planning and corporate affairs, also will conduct a series of one-on-one meetings with investment-community representatives at the conference.
ONEOK Partners, L.P. engages in the gathering, processing, storage, and transportation of natural gas in the United States. It operates in three segments: Natural Gas Gathering and Processing; Natural Gas Liquids; and Natural Gas Pipelines.
At the end of Friday’s trade, Shares of Clovis Oncology Inc (NASDAQ:CLVS), lost -0.15% to $104.10.
Clovis Oncology, declared that its Chief Executive Officer and President, Patrick J. Mahaffy, will present at the Morgan Stanley Global Healthcare Conference 2015 on Thursday, September 17, 2015 at 12:20 PM Eastern Time. The conference will be held at the Grand Hyatt Hotel in New York.
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. It is developing three product candidates which comprise Rociletinib, an oral epidermal growth factor receptor and mutant-selective covalent inhibitor that is in advanced clinical development for the treatment of non-small cell lung cancer; Rucaparib, an oral inhibitor of poly polymerase, which is in advanced clinical development for the treatment of ovarian cancer; and Lucitanib, an oral inhibitor of the tyrosine kinase that is in Phase II development for the treatment of breast and lung cancers.
Finally, Eastman Chemical Company (NYSE:EMN), ended its last trade with -0.40% loss, and closed at $69.88.
Eastman Chemical Company, was recognized by the American Chemical Society (ACS) with the Heroes of Chemistry award, an honor reserved by the ACS to celebrate innovative work in chemistry and chemical engineering that led to commercial products benefiting the world. Eastman received the award for the first time ever, and for one of the defining success stories in company history: Eastman Tritan(TM) copolyester.
The ACS bestowed the awards to Eastman and five other companies at the ACS National Meeting in Boston. Six scientists and engineers who were integral to the Tritan(TM) commercialization effort accepted the award on behalf of Eastman: Ben Barton, Emmett Crawford, Ted Germroth, Chris Killian, Tony Messina and David Porter.
“Everyone at Eastman can take pride in the Heroes of Chemistry award, because it would be impossible to count all the team members who have had a hand in making it a success,” said Steve Crawford, senior vice president and chief technology officer. “Our company transformed an entire industry with Tritan(TM). We`re grateful to the ACS for recognizing a product that makes a difference in everyday lives.”
Eastman Chemical Company, a specialty chemical company, manufactures and sells materials, chemicals, and fibers in the United States and internationally. The company’s Additives & Functional Products segment offers solvents, such as specialty coalescents and ketones and esters, glycol ethers, and alcohol solvents; cellulose and polyester-based specialty polymers, and paint additives; insoluble sulfur products; antidegradants; hydrocarbon resins; specialty intermediates, performance products, and formic acid; and alkylamine derivatives.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
